Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT04577456
Chyme Reinfusion for Type 2 Intestinal Failure
Phase: N/A
Role: Collaborator
Start: Oct 15, 2022
Completion: Oct 31, 2025